The global market for Metagenome-Assembled Genomes (MAGs) services is poised for significant growth, driven by technological advancements in sequencing, bioinformatics, and microbiome research. According to a recent report added to ResearchAndMarkets.com, the market is anticipated to expand from $1.38 billion in 2025 to $1.60 billion in 2026, marking a compound annual growth rate (CAGR) of 15.7%.
This growth trajectory is expected to continue, with projections indicating that the market will reach $2.89 billion by 2030, growing at a CAGR of 15.9% from 2026. The expansion is fueled by the increasing demand for precision microbiome-based therapeutics, the adoption of artificial intelligence in genome reconstruction, and the application of microbial analysis in agriculture. Additionally, the rise of cloud-based bioinformatics services and the exploration of uncultured microbial diversity are further contributing to this growth.
Several trends are shaping the MAGs services market. These include the adoption of hybrid genome assembly methods and the demand for high-quality metagenome binning. Long-read sequencing is gaining traction as researchers aim to analyze complex microbiomes and reconstruct comprehensive microbial genomes. Service providers are enhancing their offerings by integrating functional and comparative genomics annotation capabilities and developing customized bioinformatics pipelines.
The prevalence of infectious diseases is also expected to bolster the demand for MAGs sequencing and bioinformatics services. As urbanization and population density increase, so do opportunities for pathogen transmission, necessitating advanced microbial surveillance and analysis. MAGs services facilitate the reconstruction of microbial genomes from clinical and environmental samples, aiding in pathogen identification, outbreak monitoring, and the study of antimicrobial resistance mechanisms.
In March 2024, the Centers for Disease Control and Prevention reported an increase in tuberculosis cases in the United States, from 8,320 in 2022 to 9,615 in 2023. This rise underscores the ongoing need for technologies that enhance infectious disease research and public health responses.
Innovation remains a key competitive factor in the MAGs services industry. Companies are investing in high-resolution long-read sequencing, optimized sample preparation, and robust bioinformatics workflows to improve the accuracy and completeness of microbial genome reconstruction. In April 2024, Clinical Microbiomics A/S introduced advanced sequencing services that combine optimized sample preparation, long-read sequencing, and bioinformatics pipelines for detailed microbial identification and analysis.
Market consolidation is also enhancing technical capabilities and broadening service coverage. For example, in March 2024, Clinical Microbiomics A/S acquired DNASense ApS to integrate long-read DNA and RNA sequencing capabilities and expand microbiome services across various applications.
Geographically, North America was the largest region in the MAGs services market in 2025, while Asia-Pacific is expected to experience the fastest growth during the forecast period. The market spans several regions, including Asia-Pacific, Western and Eastern Europe, North and South America, the Middle East, and Africa. Countries analyzed in the report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy, and Spain.
The report covers various aspects of the MAGs services market, such as service types, technologies, applications, and end-users. Service types include genome assembly, annotation, data analysis, and custom bioinformatics. Technologies encompass next-generation sequencing, long-read sequencing, and AI-based analytics. Applications range from environmental microbiology to clinical diagnostics and agricultural research.
Key companies featured in the report include Thermo Fisher Scientific Inc., QIAGEN N.V., BGI Genomics Co. Ltd., and others. These companies are at the forefront of innovation in the MAGs services market, driving advancements in sequencing technologies and bioinformatics. Thermo Fisher Scientific Inc., for example, is known for its comprehensive range of products and services that support scientific research and clinical applications. QIAGEN N.V. offers a wide array of molecular diagnostic solutions, which are crucial in the analysis of genetic information. BGI Genomics Co. Ltd. is a leader in providing sequencing services and genomic solutions worldwide.
The MAGs services market is characterized by a diverse range of service offerings and technological advancements. Genome assembly services include de novo assembly, reference-guided assembly, and hybrid assembly. Genome annotation services involve structural and functional annotation, gene prediction, and pathway analysis. Data analysis services cover microbial diversity analysis, taxonomic classification, and metabolic pathway analysis. Custom bioinformatics services include workflow development, algorithm optimization, and pipeline integration.
Footnotes:
- The global MAGs services market is projected to grow from $1.38 billion in 2025 to $1.60 billion in 2026. Source.
- The market is expected to reach $2.89 billion by 2030, with a CAGR of 15.9% from 2026. Source.
- In March 2024, Clinical Microbiomics A/S acquired DNASense ApS to expand its microbiome services. Source.
Featured Image: Megapixl @ Ipopba